Michael Imboden

510 total citations
11 papers, 411 citations indexed

About

Michael Imboden is a scholar working on Immunology, Molecular Biology and Parasitology. According to data from OpenAlex, Michael Imboden has authored 11 papers receiving a total of 411 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Parasitology. Recurrent topics in Michael Imboden's work include Immunotherapy and Immune Responses (3 papers), Parasitic Infections and Diagnostics (3 papers) and T-cell and B-cell Immunology (3 papers). Michael Imboden is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Parasitic Infections and Diagnostics (3 papers) and T-cell and B-cell Immunology (3 papers). Michael Imboden collaborates with scholars based in United States and Germany. Michael Imboden's co-authors include Alexander L. Rakhmilevich, Paul M. Sondel, Zane C. Neal, Stephen D. Gillies, Ralph A. Reisfeld, Lyudmila G. Burdelya, Joel G. Turner, Hua Yu, Deborah A. Schaefer and Holger N. Lode and has published in prestigious journals such as The Journal of Immunology, Clinical Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Michael Imboden

11 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Imboden United States 10 238 155 142 69 51 11 411
Benoît Guillaume Belgium 8 220 0.9× 409 2.6× 213 1.5× 7 0.1× 20 0.4× 10 531
Christopher B. Whitehurst United States 16 153 0.6× 282 1.8× 391 2.8× 17 0.2× 9 0.2× 22 676
S L Giardina United States 11 194 0.8× 138 0.9× 94 0.7× 14 0.2× 43 0.8× 14 385
Nely Rodríguez‐Zhurbenko Cuba 6 257 1.1× 108 0.7× 38 0.3× 25 0.4× 80 1.6× 11 403
Andrea L. Volk United States 6 86 0.4× 91 0.6× 152 1.1× 14 0.2× 10 0.2× 7 396
Melissa J. Blumenthal South Africa 11 59 0.2× 77 0.5× 115 0.8× 15 0.2× 31 0.6× 21 336
Els Sturm Netherlands 8 576 2.4× 120 0.8× 188 1.3× 9 0.1× 87 1.7× 13 704
Laila Samady United Kingdom 7 152 0.6× 171 1.1× 73 0.5× 8 0.1× 19 0.4× 7 420
Agni Christodoulidou United States 4 240 1.0× 128 0.8× 31 0.2× 11 0.2× 46 0.9× 5 372
Dawn Jaquish United States 8 93 0.4× 131 0.8× 123 0.9× 8 0.1× 23 0.5× 9 380

Countries citing papers authored by Michael Imboden

Since Specialization
Citations

This map shows the geographic impact of Michael Imboden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Imboden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Imboden more than expected).

Fields of papers citing papers by Michael Imboden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Imboden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Imboden. The network helps show where Michael Imboden may publish in the future.

Co-authorship network of co-authors of Michael Imboden

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Imboden. A scholar is included among the top collaborators of Michael Imboden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Imboden. Michael Imboden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Sujun, Siqi Wu, Michael Imboden, et al.. (2020). Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa. Gene Therapy. 28(5). 223–241. 45 indexed citations
2.
Eiden, Joseph E., Carlos Fierro, Robert B. Belshe, et al.. (2018). 1970. Phase 1 Clinical Trial of Intranasal Immunization with M2-Deficient, Single Replication, Live Influenza Vaccine (M2SR): Safety and Immune Response in Adults. Open Forum Infectious Diseases. 5(suppl_1). S571–S572. 1 indexed citations
3.
Carryn, Stéphane, Deborah A. Schaefer, Michael Imboden, et al.. (2012). Phospholipases and Cationic Peptides Inhibit Cryptosporidium parvum Sporozoite Infectivity by Parasiticidal and Non-Parasiticidal Mechanisms. Journal of Parasitology. 98(1). 199–204. 29 indexed citations
4.
Imboden, Michael, Deborah A. Schaefer, Robert D. Bremel, E. Jane Homan, & Michael W. Riggs. (2012). Antibody fusions reduce onset of experimental Cryptosporidium parvum infection in calves. Veterinary Parasitology. 188(1-2). 41–47. 12 indexed citations
5.
Imboden, Michael, Michael W. Riggs, Deborah A. Schaefer, E. Jane Homan, & Robert D. Bremel. (2010). Antibodies Fused to Innate Immune Molecules Reduce Initiation ofCryptosporidium parvumInfection in Mice. Antimicrobial Agents and Chemotherapy. 54(4). 1385–1392. 12 indexed citations
6.
Neal, Zane C., Alexander L. Rakhmilevich, Ilia N. Buhtoiarov, et al.. (2004). Enhanced Activity of Hu14.18-IL2 Immunocytokine against Murine NXS2 Neuroblastoma when Combined with Interleukin 2 Therapy. Clinical Cancer Research. 10(14). 4839–4847. 76 indexed citations
7.
Neal, Zane C., Michael Imboden, Alexander L. Rakhmilevich, et al.. (2003). NXS2 murine neuroblastomas express increased levels of MHC class I antigens upon recurrence following NK-dependent immunotherapy. Cancer Immunology Immunotherapy. 53(1). 41–52. 37 indexed citations
8.
Imboden, Michael, Fushun Shi, Thomas D. Pugh, et al.. (2003). Safety of Interleukin-12 Gene Therapy Against Cancer: A Murine Biodistribution and Toxicity Study. Human Gene Therapy. 14(11). 1037–1048. 27 indexed citations
9.
Turner, Joel G., Alexander L. Rakhmilevich, Lyudmila G. Burdelya, et al.. (2001). Anti-CD40 Antibody Induces Antitumor and Antimetastatic Effects: The Role of NK Cells. The Journal of Immunology. 166(1). 89–94. 90 indexed citations
10.
Rakhmilevich, Alexander L., Michael Imboden, Zhengling Hao, et al.. (2001). Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor.. PubMed. 7(4). 952–61. 42 indexed citations
11.
Imboden, Michael, Alexander L. Rakhmilevich, Zane C. Neal, et al.. (2001). The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.. PubMed. 61(4). 1500–7. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benoît Guillaume Breakdown of academic impact, for papers by Christopher B. Whitehurst Breakdown of academic impact, for papers by S L Giardina Breakdown of academic impact, for papers by Nely Rodríguez‐Zhurbenko Breakdown of academic impact, for papers by Andrea L. Volk Breakdown of academic impact, for papers by Melissa J. Blumenthal Breakdown of academic impact, for papers by Els Sturm Breakdown of academic impact, for papers by Laila Samady Breakdown of academic impact, for papers by Agni Christodoulidou Breakdown of academic impact, for papers by Dawn Jaquish
Rankless by CCL
2026